Allscripts (MDRX) PT Lowered to $13 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Allscripts (MDRX) PT Lowered to $14.50 at RBC Capital
May 4, 2018 8:20 AM EDTRBC Capital lowered its price target on Allscripts (NASDAQ: MDRX) to $14.50 (from $17.00) while maintaining a Outperform rating.
... MoreSunTrust Robinson Humphrey Upgrades Allscripts (MDRX) to Buy
May 4, 2018 7:10 AM EDTSunTrust Robinson Humphrey upgraded Allscripts (NASDAQ: MDRX) from Hold to Buy with a price target of $16.00.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $11.52 yesterday.
... MoreAllscripts (MDRX) to Buy HealthGrid
May 3, 2018 4:52 PM EDTAllscripts (NASDAQ: MDRX), a global leader in healthcare technology, today announced that it signed a definitive agreement to acquire HealthGrid Holding Company, a mobile enterprise patient engagement platform business. The agreement represents a significant expansion of the Allscripts FollowMyHealth® platform portfolio, the companys patient engagement solution focused on connecting patients with providers. Allscripts expects to close the acquisition in the second quarter of calendar 2018, subject to the satisfaction of customary closing conditions, including the expiration or termination of the waiting period under U.S. antitrust laws.
HealthGrid is a leading mobile, enterprise... More
Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
May 3, 2018 4:04 PM EDTAllscripts (NASDAQ: MDRX) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $518.6 million versus the consensus estimate of $530.48 million.
Allscripts affirms the following financial outlook for 2018
For earnings history and earnings-related data on Allscripts (MDRX) click here.
... More